Effect of once-per-day tacrolimus versus twice-per-day ciclosporin on 3-year incidence of chronic lung allograft dysfunction after lung transplantation in Scandinavia (ScanCLAD): a multicentre randomised controlled trial

Yusen, 2015, The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report—2015; focus theme: early graft failure, J Heart Lung Transplant, 34, 1264, 10.1016/j.healun.2015.08.014 Verleden, 2019, Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment—a consensus report from the Pulmonary Council of the ISHLT, J Heart Lung Transplant, 38, 493, 10.1016/j.healun.2019.03.009 Treede, 2012, Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation, J Heart Lung Transplant, 31, 797, 10.1016/j.healun.2012.03.008 Dellgren, 2020, Design and rationale of a Scandinavian multicenter randomized study evaluating if once-daily tacrolimus versus twice-daily cyclosporine reduces the 3-year incidence of chronic lung allograft dysfunction after lung transplantation (ScanCLAD study), Adv Ther, 37, 1260, 10.1007/s12325-020-01224-1 Pocock, 1975, Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial, Biometrics, 31, 103, 10.2307/2529712 Miller, 2005, Standardisation of spirometry, Eur Respir J, 26, 319, 10.1183/09031936.05.00034805 Glanville, 2019, Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome—a consensus report from the Pulmonary Council of the ISHLT, J Heart Lung Transplant, 38, 483, 10.1016/j.healun.2019.03.008 Stewart, 2007, Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection, J Heart Lung Transplant, 26, 1229, 10.1016/j.healun.2007.10.017 Levine, 2016, Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation, J Heart Lung Transplant, 35, 397, 10.1016/j.healun.2016.01.1223 Penninga, 2013, Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients, Cochrane Database Syst Rev, 5 Burke, 1984, Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation, Chest, 86, 824, 10.1378/chest.86.6.824 Verleden, 2014, A new classification system for chronic lung allograft dysfunction, J Heart Lung Transplant, 33, 127, 10.1016/j.healun.2013.10.022 Sato, 2011, Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction, J Heart Lung Transplant, 30, 735, 10.1016/j.healun.2011.01.712 Sukkha, 2020, Trough level and tacrolimus variability of early converted once-daily tacrolimus: 1-year follow-up study, Transplant Proc, 52, 775, 10.1016/j.transproceed.2019.12.039 Wlodarczyk, 2009, Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial, Am J Transplant, 9, 2505, 10.1111/j.1600-6143.2009.02794.x Fischer, 2011, Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trial, Liver Transpl, 17, 167, 10.1002/lt.22211 Trunečka, 2010, Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation, Am J Transplant, 10, 2313, 10.1111/j.1600-6143.2010.03255.x Krämer, 2017, Efficacy of prolonged- and immediate-release tacrolimus in kidney transplantation: a pooled analysis of two large, randomized, controlled trials, Transplant Proc, 49, 2040, 10.1016/j.transproceed.2017.07.011 Jones-Hughes, 2016, Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model, Health Technol Assess, 20, 1, 10.3310/hta20620 Chambers, 2017, The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report—2017; focus theme: allograft ischemic time, J Heart Lung Transplant, 36, 1047, 10.1016/j.healun.2017.07.016 Keenan, 1995, Clinical trial of tacrolimus versus cyclosporine in lung transplantation, Ann Thorac Surg, 60, 580, 10.1016/0003-4975(95)00407-C Zuckermann, 2003, Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial, J Thorac Cardiovasc Surg, 125, 891, 10.1067/mtc.2003.71 Hachem, 2007, A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation, J Heart Lung Transplant, 26, 1012, 10.1016/j.healun.2007.07.027 Fan, 2009, Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis, Transplant Proc, 41, 1821, 10.1016/j.transproceed.2008.11.016 Yang, 2022, Systematic review and meta-analysis of calcineurin inhibitors on long-term prognosis of renal transplant patients, Transpl Immunol, 75, 10.1016/j.trim.2022.101741 Guethoff, 2013, Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine A in combination with mycophenolate mofetil after heart transplantation, Transplantation, 95, 629, 10.1097/TP.0b013e318277e378 Muduma, 2016, Systematic review and meta-analysis of tacrolimus versus ciclosporin as primary immunosuppression after liver transplant, PLoS One, 11, 10.1371/journal.pone.0160421 Chambers, 2019, The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult lung and heart-lung transplantation Report—2019; focus theme: donor and recipient size match, J Heart Lung Transplant, 38, 1042, 10.1016/j.healun.2019.08.001